Hypertension affects 30 million Mexicans

At the national level, the prevalence of Arterial hypertension (HTA) in the population over 20 years old is 30.05%, that is, currently more than 30 million Mexicans, men and women, suffer from it. According to data reported in the National Health Survey (ENSA 2000), 75% of patients hypertensive diagnosed are under 54 years old. About, Francisco Fernando Rodríguez Rosales , cardiologist doctor assigned to National Institute of Cardiology Ignacio Chávez , said: "These data demystify the belief that the hypertension It is exclusive of people in advanced age, because it also occurs in individuals of productive age who see their quality of life and family economy disrupted, since a high percentage also presents diabetes , obesity Y cholesterol high, hence the importance of detecting and controlling it properly ".

After 50 years, the prevalence increases 50%, that is, 1 in 2 people have hypertension . In this sense, women older than 50 years are more susceptible to suffer the disease that is characterized by being asymptomatic and causes serious complications, such as: develop ischemic diseases of the heart , cerebro-vascular problems and renal insufficiency . In most cases, hypertension is controlled at the moment when the patient has a balanced diet, performs physical activity and takes the pharmacological treatment prescribed by his treating physician. Although the number of medications to be taken per day may be 2 or more, which discourages prolonged treatment, coupled with the costs that affect their economy: "Currently doctors already have therapeutic options that raise the level of adherence to the treatment of our patients in the long term, as is the case of a drug that combines in a tablet 2 of the main salts used in the world for the control of hypertension (Amlodipino / Losartán ) and it is a daily intake. This is good news if we make a comparison of what a patient has to invest daily when taking both salts separately, with this new treatment the investment to control his condition is reduced significantly, "he said. Rodríguez Rosales. He added that the combination therapy of Amlodipino / Losartán offers patients of moderate and high risk, better control antihypertensive , while providing greater cardiovascular, renal and cerebral vascular protection. According to clinical studies, with the Amlodipino / Losartan combination, known in Mexico as Bicartial®, it was shown that in the long term more than 60% of patients with high pressure and risk factors remained with acceptable levels of HTA, thus reaching the goals recommended by the various guidelines for the treatment of hypertension .


Video Medicine: Hypertension: Detect, Connect, Control (March 2024).